drug protocol number

EMR062202-561

drug sponsor

Merck Serono

drug study

Erbitux (Cetuximab)

drug trial site

King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Riyadh), Prince Sultan Military Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)

drug status

Ongoing

drug phase